on OXURION (EBR:OXUR)
Oxurion Reports Transparency Notification from Atlas Special Opportunities
On June 30, 2025, Oxurion NV, a biopharmaceutical company based in Leuven, Belgium, announced the receipt of a transparency notification under Belgian law. The notification, received on June 26, 2025, from Atlas Special Opportunities II, LLC, disclosed ownership of 621,773 shares out of 8,496,303 outstanding shares. This change indicates that Atlas has crossed below the 10% threshold due to the sale of voting securities.
This development is in line with Oxurion's compliance with transparency legislation aimed at revealing significant shareholding changes. The company's strategic focus remains on therapeutic innovation and clinical research technologies. For more details, refer to the documentation on the company's website.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all OXURION news